eCF506 |
eCF506 : ATP-competitive inhibitor of SRC
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SRC |
|
|
Inhibitor
10-100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - SRC Family Members: 0.5-5.4 nM
Potency Assay Off-Target:
Radioisotope-based assay ([γ-33P] ATP) consisting of measuring 33P incorporation on the substrate (p ...
Selectivity Assessment Description:
eCF506 exclusively inhibits SRC Family Kinases. It is important to highlight that eCF506 displays ...
In Cell Selectivity Assessment
Potency: IC50 - AKT >1000 nM
Potency Assay Off-Target:
Western blot
Potency Cellular
In Vitro
SRC
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.6b00065
In Vivo Validations
Mouse, CD-1;, Zebrafish, Tg(brn3c:mGFP)
Dose: 10 mg/kg
Route of delivery:
Intravenous, Oral
Plasma half life:
2.9 h
Systemic clearance:
72.3 mL/min/Kg
Reference: --
Chemical Information
| Molecular Formula | C26H38N8O3 |
| SMILEs | COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C |
| InChI | InChI=1S/C26H38N8O3/c1-26(2,3)37-25(35)30-19-8-7-17(15-20(19)36-6)22-21-23(27)28-16-29-24(21)34(31-22)14-13-33-11-9-18(10-12-33)32(4)5/h7-8,15-16,18H,9-14H2,1-6H3,(H,30,35)(H2,27,28,29) |
| Molecular weight | 510.31 Da |
| AlogP | 3.4571 |
| HBond acceptors | 11 |
| HBond donors | 3 |
| Atoms | 75 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.